TY - JOUR
T1 - Assessing COVID-19 pandemic impacts on the health of PWID using a novel data sharing model
AU - Bradley, Heather
AU - Luisi, Nicole
AU - Carter, Anastasia
AU - Pigott, Terri D.
AU - Abramovitz, Daniela
AU - Allen, Sean T.
AU - Asher, Alice
AU - Austin, Chelsea
AU - Bartholomew, Tyler S.
AU - Baum, Marianna
AU - Board, Amy
AU - Boodram, Basmattee
AU - Borquez, Annick
AU - Brookmeyer, Kathryn A.
AU - Buchacz, Kate
AU - Burnett, Janet
AU - Cooper, Hannah L.F.
AU - Crepaz, Nicole
AU - Debeck, Kora
AU - Feinberg, Judith
AU - Fong, Chunki
AU - Freeman, Edward
AU - Furukawa, Nathan Woo
AU - Genberg, Becky
AU - Gorbach, Pamina
AU - Hagan, Holly
AU - Hayashi, Kanna
AU - Huriaux, Emalie
AU - Hurley, Hermione
AU - Keruly, Jeanne
AU - Kristensen, Kathleen
AU - Lai, Shenghan
AU - Martin, Natasha K.
AU - Mateu-Gelabert, Pedro
AU - McClain, Gregory M.
AU - Mehta, Shruti
AU - Yin, Wing
AU - Reynoso, Marley
AU - Strathdee, Steffanie
AU - Torigian, Nicole
AU - Weng, Chenziheng Allen
AU - Westergaard, Ryan
AU - Young, April
AU - des Jarlais, Don C.
N1 - Publisher Copyright:
© 2024 Lippincott Williams and Wilkins. All rights reserved.
PY - 2024
Y1 - 2024
N2 - Objective: Using an innovative data sharing model, we assessed the impacts of the COVID-19 pandemic on the health of people who inject drugs (PWID). Design: The PWID Data Collaborative was established in 2021 to promote data sharing across PWID studies in North America. Contributing studies submitted aggregate data on 23 standardized indicators during four time periods: pre-pandemic (Mar 2019 – Feb 2020), early-pandemic (Mar 2020 – Feb 2021), mid-pandemic (Mar 2021 - Feb 2022), and late pandemic (Mar 2022 - Feb 2023). Methods: We present study-specific and meta-analyzed estimates for the percentage of PWID who took medications for opioid use disorder, received substance use treatment, shared syringes or injection equipment, had a mental health condition, had been incarcerated, or had experienced houselessness. To examine change over time across indicators, we fit a random effects meta-regression model to prevalence estimates using time as a moderator. Results: Thirteen studies contributed estimates to the Data Collaborative on these indicators, representing 6,213 PWID interviews. We observed minimal change across prevalence of the six indicators between the pre-pandemic (March 2019 – February 2020) and three subsequent time periods, overall or within individual studies. Considerable heterogeneity was observed across study- and time-specific estimates. Conclusions: Limited pandemic-related change observed in indicators of PWID health is likely a result of policy and supportive service-related changes and may also reflect resilience among service providers and PWID themselves. The Data Collaborative is an unprecedented data sharing model with potential to greatly improve the quality and timeliness of data on the health of PWID.
AB - Objective: Using an innovative data sharing model, we assessed the impacts of the COVID-19 pandemic on the health of people who inject drugs (PWID). Design: The PWID Data Collaborative was established in 2021 to promote data sharing across PWID studies in North America. Contributing studies submitted aggregate data on 23 standardized indicators during four time periods: pre-pandemic (Mar 2019 – Feb 2020), early-pandemic (Mar 2020 – Feb 2021), mid-pandemic (Mar 2021 - Feb 2022), and late pandemic (Mar 2022 - Feb 2023). Methods: We present study-specific and meta-analyzed estimates for the percentage of PWID who took medications for opioid use disorder, received substance use treatment, shared syringes or injection equipment, had a mental health condition, had been incarcerated, or had experienced houselessness. To examine change over time across indicators, we fit a random effects meta-regression model to prevalence estimates using time as a moderator. Results: Thirteen studies contributed estimates to the Data Collaborative on these indicators, representing 6,213 PWID interviews. We observed minimal change across prevalence of the six indicators between the pre-pandemic (March 2019 – February 2020) and three subsequent time periods, overall or within individual studies. Considerable heterogeneity was observed across study- and time-specific estimates. Conclusions: Limited pandemic-related change observed in indicators of PWID health is likely a result of policy and supportive service-related changes and may also reflect resilience among service providers and PWID themselves. The Data Collaborative is an unprecedented data sharing model with potential to greatly improve the quality and timeliness of data on the health of PWID.
KW - cohort study
KW - COVID-19 pandemic disruption
KW - houselessness
KW - incarceration
KW - medications for opioid use disorder
KW - mental health
KW - meta-regression
KW - People who inject drugs
KW - substance use disorder treatment
KW - syringe sharing
UR - http://www.scopus.com/inward/record.url?scp=85210951406&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85210951406&partnerID=8YFLogxK
U2 - 10.1097/QAD.0000000000004076
DO - 10.1097/QAD.0000000000004076
M3 - Article
AN - SCOPUS:85210951406
SN - 0269-9370
JO - AIDS
JF - AIDS
M1 - 10.1097/QAD.0000000000004076
ER -